mdgl stocktwits：Madrigal Pharmaceuticals (MDGL) Stock Forecast & Price ...
Madrigal Pharmaceuticals (MDGL) Stock Forecast & Price ...
Basedon8WallStreetanalystsoffering12monthpricetargetsforMadrigalPharmaceuticalsinthelast3months.Theaveragepricetargetis$330.43witha ...。其他文章還包含有：「Earnings」、「MadrigalPharmaceuticalsInc(MDGL)Fundamental&...」、「MadrigalPharmaceuticalsInc(MDGL)News」、「MadrigalPharmaceuticalsInc(MDGL)sentimentscore...」、「MadrigalPharmaceuticals,Inc.(MDGL)StockPrice」、「MDGLConversationsFromStoc...
查看更多 離開網站
Earnings
https://stocktwits.com
Checkout Madrigal Pharmaceuticals Inc (MDGL) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods.
Madrigal Pharmaceuticals Inc (MDGL) Fundamental & ...
https://stocktwits.com
Get all financial information for Madrigal Pharmaceuticals Inc (MDGL) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, ...
Madrigal Pharmaceuticals Inc (MDGL) News
https://stocktwits.com
Find Madrigal Pharmaceuticals Inc (MDGL) news, corporate events, press releases, latest company updates and headlines.
Madrigal Pharmaceuticals Inc (MDGL) sentiment score ...
https://stocktwits.com
Discover Madrigal Pharmaceuticals Inc (MDGL) market and community sentiment, movement in message volume, participation score and buzz level in the ...
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Price
https://finance.yahoo.com
MDGL - Madrigal Pharmaceuticals, Inc. NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 236.54. -11.99 (-4.82%). At close: February 23 04:00PM EST.
MDGL Conversations From StockTwits
https://stocknews.com
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe ...
MDGL Madrigal Pharmaceuticals Inc
https://stocktwits.com
MDGL Madrigal Pharmaceuticals Inc. 5,628. $236.54. $11.99. (4.82%). Today. Market Cap, $4.67B. 52-Wk High, $322.67. 52-Wk Low, $119.76. ST Data. Watchers.
Synta Pharmaceuticals Corp. (SNTA) News
https://stocktwits.com
--- - Zacks Investment Research lowered shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) from a hold rating to a sell rating in a report published on Wednesday ...